https://www.selleckchem.com/products/go-203.html
3-54.1) 34.7 months (95% CI 34.0-35.6) respectively]. The 5-year OS rate of BO MBC patients was 43.4% (95% CI 41.7-45.2). They also had a better PFS1 [13.1 months (95% CI 12.6-13.8) 8.5 months (95% CI 8.3-8.7), respectively]. This observation could be repeated in all subtypes. BO disease was an independent prognostic factor of OS [hazard ratio 0.68 (95% CI 0.65-0.72), 0.0001]. Results were concordant in all analyses. BO MBC patients have better outcomes compared with non-BO MBC, consistently, through all MBC subtypes. BO MBC patien
Like
Comment
Share
